Form D · Biotechnology
TETmedical, Inc.
Fair Haven, NJ · CIK 0001980705
Offering snapshot reported Jun 24, 2026 · SEC filing
- Reported sold
- $3.53M Offering amount: $9.81M
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 12, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2026 | Initial | $3,533,611 | No comparison | 45 | SEC filing |
| Jun 13, 2023 | Initial | $2,461,986 | No comparison | 70 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588441
Source: Form D, filed Jun 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christine Bunt | Director |
| Roy Cohen | Executive |
| John Conley | Director |
| David Fischell | Director, Executive |
| Alex Travis | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
71 Riverlawn Drive
Fair Haven, NJ, 07704
Fair Haven, NJ, 07704